NMD Pharma A/S, which is developing clinical stage treatments for neuromuscular diseases, has appointed Morten Bull as general counsel and head of people and business services as it develops into late-stage clinical pipeline. Mr Bull had been general counsel on a consultancy basis since June 2023. Before joining NMD Pharma A/S, Mr Bull was executive director and global head of IP and R&D Legal at LEO Pharma A/S.
NMD Pharma announced the appointment on 22 January 2024.
Copyright 2024 Evernow Publishing Ltd